{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:02:53Z","timestamp":1790870573437,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Measles resurgence across Europe has renewed attention to immunity gaps in healthcare environments. Following decades of sub-optimal coverage, Italy implemented mandatory vaccination under Law 119\/2017 to counteract declining rates. However, young adults entering medical training represent a transitional cohort with heterogeneous exposures to natural infection versus vaccination. This study evaluated the evolution of measles immunity among medical students and healthcare trainees, assessing the impact of vaccination policies and the operational efficacy of an on-site catch-up vaccination pathway. Methods: We conducted an observational study of 1014 medical-area students and young healthcare workers aged 18\u201335 years undergoing occupational surveillance in 2025 at Policlinico Tor Vergata, Rome. Measles IgG antibodies were quantified by chemiluminescent immunoassay (VIRCLIA\u00ae S\/CO &gt; 1.0 defining protection). Findings were compared with baseline institutional data from 2020. Results: Overall seroprotection in 2025 was 91.8% (931\/1014). Stratification showed no significant differences by sex (92.6% female vs. 90.1% male; p = 0.168), age group (92.8% in 18\u201325 vs. 90.9% in 26\u201335 years; p = 0.249), or nationality. Among the 83 sub-threshold individuals, 42.2% had documented prior immunization, reflecting secondary humoral waning rather than primary vaccine failure. On-site revaccination raised final seroprotection to 95.4%. Comparative assessment demonstrated a significant progressive shift from natural wild-type exposure toward vaccine-induced immunity over the past decade. Conclusions: Mandatory vaccination policies have stabilized baseline protection, yet waning humoral titers among vaccinated young adults present unique operational challenges. A structured occupational protocol combining serological screening, historical verification, and on-site revaccination effectively closes nosocomial immunity gaps.<\/jats:p>","DOI":"10.3390\/vaccines14090835","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:35:28Z","timestamp":1790868928000},"page":"835","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Measles Seroprotection and Catch-Up Vaccination in Medical Students and Other Healthcare Workers at a Large Teaching Hospital: Positive Impact of Mandatory Italian Vaccination Policies"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2292-3338","authenticated-orcid":false,"given":"Cristiana","family":"Ferrari","sequence":"first","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"},{"name":"PhD Program in Social, Occupational and Medico-Legal Sciences, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Francesco","family":"Cama","sequence":"additional","affiliation":[{"name":"PhD Program in Social, Occupational and Medico-Legal Sciences, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Lavinia","family":"Ponzo","sequence":"additional","affiliation":[{"name":"PhD Program in Social, Occupational and Medico-Legal Sciences, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Ilenia","family":"Mazzocchi","sequence":"additional","affiliation":[{"name":"PhD Program in Social, Occupational and Medico-Legal Sciences, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Claudia","family":"Salvi","sequence":"additional","affiliation":[{"name":"PhD Program in Social, Occupational and Medico-Legal Sciences, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3970-7566","authenticated-orcid":false,"given":"Lorenzo","family":"Ippoliti","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"},{"name":"PhD Program in Social, Occupational and Medico-Legal Sciences, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"},{"name":"Faculty of Medicine, Saint Camillus International University of Health Sciences, 00131 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Andrea","family":"Magrini","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2470-6107","authenticated-orcid":false,"given":"Luca","family":"Coppeta","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archpedi.1962.02080020347030","article-title":"Development of Attenuated Measles Virus Vaccines: A Summary of Recent Investigation","volume":"103","author":"Enders","year":"1962","journal-title":"Am. J. Dis. Child."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(21)02004-3","article-title":"Measles","volume":"399","author":"Hubschen","year":"2022","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.1093\/infdis\/jiaa793","article-title":"Measles in the 21st century: Progress toward achieving and sustaining elimination","volume":"224","author":"Gastanaduy","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Coughlin, M.M., Beck, A.S., Bankamp, B., and Rota, P.A. (2017). Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Viruses, 9.","DOI":"10.3390\/v9010011"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(73)91946-6","article-title":"Further epidemiological studies of subacute sclerosing panencephalitis","volume":"302","author":"Detels","year":"1973","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0002-9343(81)90203-5","article-title":"Measles pneumonia in young adults. An analysis of 106 cases","volume":"71","author":"Gremillion","year":"1981","journal-title":"Am. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198401193100301","article-title":"Measles encephalomyelitis-clinical and immunologic studies","volume":"310","author":"Johnson","year":"1984","journal-title":"New Engl. J. Med."},{"key":"ref_8","first-page":"1083","article-title":"Virus pneumonia following measles. A virological and histological study of autopsy material","volume":"50","author":"Kipps","year":"1976","journal-title":"S. Afr. Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s15010-024-02186-0","article-title":"Guarding the gatekeepers: A comprehensive approach to control nosocomial measles","volume":"52","author":"Limavady","year":"2024","journal-title":"Infection"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1542\/peds.103.5.1057","article-title":"Measles immunization in HIV-infected children","volume":"103","author":"Halsey","year":"1999","journal-title":"Pediatrics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1016\/j.vaccine.2013.10.046","article-title":"Vaccination policies for healthcare workers in Europe","volume":"32","author":"Maltezou","year":"2014","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/eurpub\/ckaa179","article-title":"Coverage rates against vaccine-preventable diseases among healthcare workers in Sicily (Italy)","volume":"31","author":"Ledda","year":"2021","journal-title":"Eur. J. Public Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1542\/peds.63.2.346","article-title":"Measles vaccination","volume":"63","author":"Halsey","year":"1979","journal-title":"Pediatrics"},{"key":"ref_14","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3201\/eid3009.240150","article-title":"Onward virus transmission after measles secondary vaccination failure","volume":"30","author":"Tranter","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"ref_16","unstructured":"Centers for Disease Control and Prevention (2026, July 20). Measles: Infection Control in Healthcare Personnel. Updated 5 April 2024, Available online: https:\/\/www.cdc.gov\/infection-control\/hcp\/healthcare-personnel-epidemiology-control\/measles.html."},{"key":"ref_17","unstructured":"Ministero Della Salute (2026, July 20). Piano Nazionale di Eliminazione del Morbillo e Della Rosolia Congenita, Available online: https:\/\/www.salute.gov.it\/new\/it\/pubblicazione\/piano-nazionale-di-eliminazione-del-morbillo-e-della-rosolia-congenita\/."},{"key":"ref_18","unstructured":"Ministero Della Salute (2017). Italian National Vaccine Prevention Plan (Piano Nazionale Prevenzione Vaccinale 2017\u20132019)."},{"key":"ref_19","unstructured":"Ministero Della Salute (2023). Italian National Vaccine Prevention Plan (Piano Nazionale Prevenzione Vaccinale) 2023\u20132025."},{"key":"ref_20","unstructured":"Repubblica Italiana (2017). Legge 31 luglio 2017, n. 119: Conversione in legge, con modificazioni, del decreto-legge 7 giugno 2017, n. 73, recante disposizioni urgenti in materia di prevenzione vaccinale. Gazzetta Ufficiale, Istituto Poligrafico e Zecca Dello Stato."},{"key":"ref_21","unstructured":"European Centre for Disease Prevention and Control (2024). Measles. Annual Epidemiological Report for 2023."},{"key":"ref_22","unstructured":"European Centre for Disease Prevention and Control (2024). Measles on the Rise in the EU\/EEA: Considerations for Public Health Response."},{"key":"ref_23","unstructured":"Istituto Superiore di Sanita (2025). Morbillo & Rosolia News, N. 80-Gennaio 2025, ISS."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Plans-Rubi\u00f3, P. (2025). Measles Vaccination Coverage and Anti-Measles Herd Immunity Levels in the World and WHO Regions Worsened from 2019 to 2023. Vaccines, 13.","DOI":"10.20944\/preprints202501.0272.v1"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ferrari, C., Somma, G., Caputi, V., Treglia, M., Pallocci, M., Cenko, F., Buonomo, E., Carestia, M., Di Giampaolo, L., and Olesen, O.F. (2024). Low Rates of Immunity among Medical Students and Residents in the Era of the Resurgence of Measles. Pathogens, 13.","DOI":"10.3390\/pathogens13090784"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2252681","DOI":"10.1080\/21645515.2023.2252681","article-title":"Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era","volume":"19","author":"Ferrari","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2174\/1874944502013010692","article-title":"A cross-sectional serological study for measles among Italian medical students in 2020","volume":"13","author":"Iannuzzi","year":"2020","journal-title":"Open Public Health J."},{"key":"ref_28","unstructured":"Vircell, S.L. (2015). MEASLES VIRCLIA\u00ae IgG MONOTEST (VCM054): Instructions for Use, Vircell. Available online: https:\/\/www.biorus.ae\/wp-content\/uploads\/2023\/02\/MEASLES-VIRCLIA-IgG-MONOTEST_VCM054_EN_compressed.pdf."},{"key":"ref_29","unstructured":"European Medicines Agency (2012). Priorix: Article 30 Referral\u2014Harmonised Product Information, European Medicines Agency (EMA). Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/priorix."},{"key":"ref_30","unstructured":"European Medicines Agency (2006). M-M-RVaxPro: EPAR\u2014Product Information, European Medicines Agency (EMA). Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/m-m-rvaxpro."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/infdis\/jiz508","article-title":"Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study","volume":"221","author":"Bianchi","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/infdis\/172.6.1591","article-title":"Cellular immunity in measles vaccine failure: Demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination","volume":"172","author":"Ward","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1201-9712(98)90116-3","article-title":"Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination","volume":"2","author":"Hayney","year":"1998","journal-title":"Int. J. Infect. Dis."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/835\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:37:29Z","timestamp":1790869049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090835"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090835","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}